ERVW-1 and HIV-1 infection: CD4mc can also inhibit HIV-1 infection more effectively than sCD4 by prematurely activating Env, leading to irreversible inactivation, and was found to be significantly more potent against a broad range of HIV-1 viruses than sCD4 (45).